Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial

Blood (2024) 144 (Supplement 1): 3563.

https://doi.org/10.1182/blood-2024-200574

Published: 2024

Journal Articles

The First Real-World Experience with Betibeglogene Autotemcel (beti-cel) Gene Therapy Treatment for Transfusion-Dependent β-Thalassemia (TDT)

Joachim B. Kunz, Eva Roth, Adil Mirza, Johann Greil, Petra Pavel, Anita Schmitt, Michael Schmitt, Alexander Kunz, Andreas E. Kulozik

Blood (2021) 138 (Supplement 1): 4917.

https://doi.org/10.1182/blood-2021-148460

Published: 2021

Journal Articles

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Blood (2018) 132 (Supplement 1): 3354.

https://doi.org/10.1182/blood-2018-99-110980

Published: 2018

Journal Articles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Blood (2018) 132 (Supplement 1): 603.

https://doi.org/10.1182/blood-2018-99-110599

Published: 2018

Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Blood (2018) 132 (Supplement 1): 604.

https://doi.org/10.1182/blood-2018-99-110124

Published: 2018

Journal Articles

Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product "MSC-Ffm" Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients

Blood (2017) 130 (Supplement 1): 514.

https://doi.org/10.1182/blood.V130.Suppl_1.514.514

Published: 2017

Journal Articles

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD PhD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 214.

https://doi.org/10.1182/blood.V130.Suppl_1.214.214

Published: 2017

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Christiane Siewert, PhD, Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 389.

https://doi.org/10.1182/blood.V128.22.389.389

Published: 2016

Journal Articles

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Murat Aktas, Philipp Dresing, PhD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 2172.

https://doi.org/10.1182/blood.V128.22.2172.2172

Published: 2016

Journal Articles

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Blood (2016) 127 (25): 3281–3290.

https://doi.org/10.1182/blood-2015-12-684498

Published: 2016

Includes: Supplemental data

Journal Articles

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Judith Feucht, Kathrin Opherk, Peter Lang, Simone Kayser, Lena Hartl, Wolfgang Bethge, Susanne Matthes-Martin, Peter Bader, Michael H. Albert, Britta Maecker-Kolhoff, Johann Greil, Hermann Einsele, Paul-Gerhardt Schlegel, Friedhelm R. Schuster, Bernhard Kremens, Claudia Rossig, Bernd Gruhn, Rupert Handgretinger, Tobias Feuchtinger

Blood (2015) 125 (12): 1986–1994.

https://doi.org/10.1182/blood-2014-06-573725

Published: 2015

Includes: Supplemental data

Journal Articles

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Anne Kruchen, PhD, Tanja Stahl, Friederike Gieseke, PhD, Thomas MC Binder, MD, Zakir Oezcan, PhD, Roland Meisel, MD, Hermann Kreyenberg, PhD, Peter Bader, Bernd Gruhn, MD, Johann Greil, MD, Matthias Pfeiffer, MD, Michaela Doering, MD, Rupert Handgretinger, Boris Fehse, Prof, Ingo Mueller, MD

Blood (2014) 124 (21): 1242.

https://doi.org/10.1182/blood.V124.21.1242.1242

Published: 2014

Journal Articles

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Blood (2013) 122 (21): 4591.

https://doi.org/10.1182/blood.V122.21.4591.4591

Published: 2013

Journal Articles

Whole Exome Sequencing Identifies Novel Lyst-Missense Mutations In Incomplete Childhood Chediak-Higashi-Syndrome Presenting As Hemphagocytic Lymphohistiocytosis (HLH)

Joachim Kunz, MD, Tobias Rausch, PhD, Obul R Bandapalli, PhD, Adrian M Stuetz, PhD, Johann Greil, MD, Ingrid Hausser, MD, Jan Korbel, PhD, Andreas E Kulozik, MD, PhD

Blood (2013) 122 (21): 3479.

https://doi.org/10.1182/blood.V122.21.3479.3479

Published: 2013

Journal Articles

Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells

Johann Greil, MD, Christian Kleist, PhD, Elisabeth Mohr, PhD, Flavius Sandra-Petrescu, PhD, Lucian Jiga, MD, PhD, Laura Dittmar, Venkata Satagopam, PhD, Haydar Demirdizen, Michael Hundemer, MD, Luis Becker, MD, Peter Lang, MD, Gerhard Opelz, MD, Peter Terness, MD

Blood (2013) 122 (21): 4457.

https://doi.org/10.1182/blood.V122.21.4457.4457

Published: 2013

Journal Articles

SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b

Cornelia Zeidler, MD, Kinan Kafa, Martin G. Sauer, MD, Britta Maecker-Kolhoff, Johann Greil, MD, Karl Welte, MD, Christian P Kratz, MD, Karl-Walter Sykora

Blood (2012) 120 (21): 4402.

https://doi.org/10.1182/blood.V120.21.4402.4402

Published: 2012

Journal Articles

Whole-Exome Sequencing Links CARD11 Inactivation with SCID

Johann Greil, MD, Tobias Rausch, PhD, Thomas Giese, MD, Obul Reddy Bandapalli, PhD, Volker Daniel, MD, PhD, Isabelle Bekeredjian-Ding, PhD, Adrian M Stuetz, PhD, Christoph Drees, PhD, Susanne Roth, MD, Jürgen Ruland, MD, Jan Korbel, PhD, Andreas E Kulozik, MD, PhD

Blood (2012) 120 (21): 258.

https://doi.org/10.1182/blood.V120.21.258.258

Published: 2012

Journal Articles

ANGIOPOIETIN1 - a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner

Patricia Garrido Castro, Dipl.-Biochem., Simon Bomken, MD, Lidija Seslija, Ronald Stam, PhD, Elda S Latif, Michael A Batey, MPhil, Hesta McNeill, Rob Pieters, MD, PhD, Josef Vormoor, MD, Prof., Johann Greil, MD, Olaf Heidenreich, PhD

Blood (2010) 116 (21): 66.

https://doi.org/10.1182/blood.V116.21.66.66

Published: 2010

Journal Articles

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Vanya Icheva, Kathrin Opherk, Wolfgang A. Bethge, Simone Kayser, Johann Greil, MD, Rupert Handgretinger, MD, PhD, Peter Lang, Tobias F. Feuchtinger, MD

Blood (2010) 116 (21): 2342.

https://doi.org/10.1182/blood.V116.21.2342.2342

Published: 2010

NARROW

Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial

The First Real-World Experience with Betibeglogene Autotemcel (beti-cel) Gene Therapy Treatment for Transfusion-Dependent β-Thalassemia (TDT)

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product "MSC-Ffm" Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Whole Exome Sequencing Identifies Novel Lyst-Missense Mutations In Incomplete Childhood Chediak-Higashi-Syndrome Presenting As Hemphagocytic Lymphohistiocytosis (HLH)

Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells

SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b

Whole-Exome Sequencing Links CARD11 Inactivation with SCID

ANGIOPOIETIN1 - a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only